FAM220BP
Putative protein FAM220BP
Also known as: F220P_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for FAM220BP in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
271 residues, UniProt reviewed canonical sequence.
>B1ANY3|FAM220BP
1 MRDRRGPLGT CLAQVQWAGG GDSDKLSYSL KKRMPTEGPW PADAPSWMNK PAVDGNSQSE
61 ALSLEMAGLS LPSGGPVLPY VKESARRNPA SAATPSAAVG LFPAPTEYFA RVSCSGVEAL
121 GRDWLGGGPR ATHGHRGQCP KGEPRVSRLT RHQKLPEMGS FWDDPPSAFP SGLGSELEPS
181 CLHSILSATL HACPEVLLKD ETKRIFLDLL NPMFSKQTIE FKKMFKSTSD GLQITLGLLA
241 LQHFELANSL CHSLKYKQNN ASRLILRVVL ELocalizationUniProt · AlphaFold · HPA
Whether an antibody against FAM220BP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.64
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FAM220BP as an antibody target. Whether an autoantibody or antibody against FAM220BP could matter depends on whether native FAM220BP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FAM220BP is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FAM220BP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...